IFI-M · CAK Tri-Axis Balanced Series

Specimen SS-F-M3-02107 // MULTI-AXIS · IFI-M

CAK Tri-Axis Balanced Series II-BL

Mentha × piperita

Peppermint

Tier IICAK Tri-Axis Balanced Series

Target Trait

1.38×

fold-change

Cooling+Astringency+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-02107

Genomic Edits

7

GC Content

47%

Construct Length

4,667 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

TRPM8 + Polyphenol-astringency axis + CaSR

IFI Score

138

Pathway Edits

  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent CAK pathway operation
  • Cross-pathway regulatory circuit for balanced CAK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, Polyphenol-astringency axis, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (CAK) with cross-pathway flux managementBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II CAK triple-axis construct for advanced multi-modal sensory architecture combining cooling, astringency, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities